$2.00
1.48% today
NYSE, Sep 24, 08:08 pm CET
ISIN
JE00BPG99318
Symbol
WALD

Waldencast Stock price

$2.03
+0.27 15.34% 1M
-1.12 35.56% 6M
-1.99 49.50% YTD
-1.78 46.72% 1Y
-6.17 75.24% 3Y
-7.82 79.39% 5Y
-7.82 79.39% 10Y
-7.82 79.39% 20Y
NYSE, Closing price Tue, Sep 23 2025
-0.05 2.17%
ISIN
JE00BPG99318
Symbol
WALD

Key metrics

Basic
Market capitalization
$252.8m
Enterprise Value
$404.6m
Net debt
$151.8m
Cash
$14.8m
Shares outstanding
122.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.6 | 0.8
EV/Sales
1.0 | 1.3
EV/FCF
negative
P/B
0.4
Financial Health
Equity Ratio
67.9%
Return on Equity
-6.4%
ROCE
-9.0%
ROIC
-8.4%
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$405.5m | $302.3m
EBITDA
$-21.0m | $48.5m
EBIT
$-81.1m | $-27.0m
Net Income
$-52.5m | $-51.6m
Free Cash Flow
$-11.8m
Growth (TTM | estimate)
Revenue
23.8% | 10.4%
EBITDA
- | 650.3%
EBIT
30.8% | 49.7%
Net Income
56.0% | -21.5%
Free Cash Flow
-
Margin (TTM | estimate)
Gross
70.5%
EBITDA
-5.2% | 16.0%
EBIT
-20.0%
Net
-13.0% | -17.1%
Free Cash Flow
-2.9%
More
EPS
$-0.5
FCF per Share
$-0.1
Short interest
2.2%
Employees
335
Rev per Employee
$820.0k
Show more

Is Waldencast a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.

Waldencast Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Waldencast forecast:

9x Buy
75%
3x Hold
25%

Analyst Opinions

12 Analysts have issued a Waldencast forecast:

Buy
75%
Hold
25%

Financial data from Waldencast

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
405 405
24% 24%
100%
- Direct Costs 120 120
2% 2%
29%
286 286
36% 36%
71%
- Selling and Administrative Expenses 365 365
14% 14%
90%
- Research and Development Expense - -
-
-
-21 -21
-
-5%
- Depreciation and Amortization 60 60
-
15%
EBIT (Operating Income) EBIT -81 -81
31% 31%
-20%
Net Profit -53 -53
56% 56%
-13%

In millions USD.

Don't miss a Thing! We will send you all news about Waldencast directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Waldencast Stock News

Neutral
GlobeNewsWire
14 days ago
U.S. Launch Planned in 2026 and Positions Obagi Medical as a Leading Dermatological Megabrand at the Convergence of Integrated Skincare and Aesthetics While Doubling its Addressable Market U.S. Launch Planned in 2026 and Positions Obagi Medical as a Leading Dermatological Megabrand at the Convergence of Integrated Skincare and Aesthetics While Doubling its Addressable Market
Neutral
GlobeNewsWire
about one month ago
Obagi Medical delivers H1 2025 double-digit growth in its Core Strategic Channels. Novaestiq Acquisition Doubles the Brand's Addressable Market in the U.S.
Neutral
GlobeNewsWire
2 months ago
Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi Medical at the forefront of health, beauty and aesthetics convergence LONDON, July 23, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced that it has acquired Novaesti...
More Waldencast News

Company Profile

Waldencast Plc develops and operates a beauty and wellness platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It intends to seek brands with a direct connection to consumers whose goals include pursuing social responsibility, inclusiveness, sustainability, and transparency. The company was founded by Michel Brousset and Hind Sebti on December 8, 2020 and is headquartered in White Plains, NY.

Head office Jersey
CEO Michel Brousset
Employees 335
Founded 2020
Website www.waldencast.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today